FDA Approves Two Combination Therapie... - HFI Connect - Hep...

HFI Connect - Hepatitis

959 members1,215 posts

FDA Approves Two Combination Therapies for HIV

mwright profile image
0 Replies

The FDA recently approved two new combination therapies for the treatment of HIV infection in adults. Both therapies are pharmacoenhanced protease inhibitors (PIs). Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg cobicistat (a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more bit.ly/1yga8lR

Written by
mwright profile image
mwright
To view profiles and participate in discussions please or .
Read more about...